Febuxostat is a 2-arylthiazole derivative that achieves its therapeutic effect of decreasing serum uric acid by selectively inhibiting XO.
Febuksostaat on 2- arüültiasooli derivaat, mille ravitoime saavutatakse seerumi kusihappetaseme alandamise teel XO selektiivse inhibeerimise kaudu.